Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006207:Half-Life; D006801:Humans; D007278:Injections, Spinal; D007938:Leukemia / Q000134:cerebrospinal fluid / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008297:Male; D008578:Meninges / Q000473:pathology*; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000134:cerebrospinal fluid* / Q000627:therapeutic use; D009422:Nervous System Diseases / Q000139:chemically induced*; D013118:Spinal Cord Diseases / Q000139:chemically induced
D008727:Methotrexate